AER 001

DRUG3 trials

Sponsors

Aerovance, Inc.

Conditions

Allergic AsthmaAsthma

Phase 1

A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects

CompletedNCT00785668

Aerovance, Inc.Asthma

Start: 2007-11-30End: 2008-02-29Updated: 2008-11-05

Phase 2

A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)

CompletedNCT00535028

Aerovance, Inc.Allergic Asthma

Start: 2005-01-31End: 2005-05-31Updated: 2007-09-26

Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics

CompletedNCT00535431

Aerovance, Inc.Allergic Asthma

Start: 2005-12-31End: 2006-10-31Updated: 2007-09-26

Related Papers

Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies.

2007-10-01417 citations